Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:6 Issue:5 Number:5 ISSN#:2563-5476
RCT
ACE Report #10199
Ace Report Cover Arthroplasty

Similar blood loss and lower cost with oral TXA vs. both IA TXA and IV TXA in total hip arthroplasty


Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Oral vs Intravenous vs Topical Tranexamic Acid in Primary Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Study

J Arthroplasty. 2018 Mar;33(3):786-793

Contributing Authors: FX Pei ZK Zhou HY Wang D Wang ZY Luo K Zhou

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

180 patients scheduled for total hip arthroplasty were randomized to oral tranexamic acid, intravenous tranexamic acid, or intraarticular tranexamic acid. Results demonstrated no significant differences between the three groups in hemoglobin drop, total blood loss, or transfusion rate. Additionally, no patient in any of the groups developed DVT or PE. Cost analysis demonstrated significantly lower...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.